Radiation+immunotherapy can slow tumor growth for some patients with metastatic NSCLC – EurekAlert (press release)
|
Radiation+immunotherapy can slow tumor growth for some patients with metastatic NSCLC
EurekAlert (press release) SAN DIEGO, September 24, 2017 – A new study involving patients with stage IV cancer finds that treatment with radiation therapy and immunotherapy can halt the growth of tumors by stimulating the body's immune system to attack the cancer. In the phase … Immune response prognostic for prostate cancer survival, recurrence and response to radiation therapy Adding radiation to chemotherapy may dramatically improve survival for advanced-stage NSCLC patients |
